| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Tequin, Antibiotic For Respiratory Infections, Approved By FDA NEW YORK, NY -- January 6, 2000 -- The Food and Drug Administration has just approved a new type of quinolone antibiotic called Tequin(TM)(gatifloxacin). The once a day medication safely and effectively treats those suffering from respiratory infections caused by susceptible bacteria. The new antibiotic has an 8-methoxy segment that appears to decrease the rate of the development of antimicrobial resistance of gram-positive bacteria. The incidence of respiratory tract infections -- such as sinusitis, bronchitis and pneumonia -- has increased almost 50 percent in the past decade in the U.S. -- to about 125 million cases per year. Pneumonia alone accounts for 4 million deaths worldwide and over 50,000 deaths annually in the U.S., making it the 6th leading cause of death.
|